A Changing Role of TACE in the Era of ICI plus Anti-VEGFTKI plus

THB 69,699.00 THB 99,999.00

sale

Identifying Feeding Arteries During TACE of Hepatic Tumors tace

Taking TACE to the next level · DEM-TACE treatments reach high complete response rates · % Complete response rate leading to over 4 years overall survival

tace TACE is generally indicated in the setting of unresectable hepatocellular carcinoma Where curative options for hepatocellular carcinoma (such A Changing Role of TACE in the Era of ICI plus Anti-VEGFTKI plus TACE: From Total Embolization to Partial Embolization EMERALD-1 is a randomised, double-blind, placebo-controlled, multicentre, global Phase III trial of Imfinzi plus TACE concurrently, followed by

เรือ จำลอง Taking TACE to the next level · DEM-TACE treatments reach high complete response rates · % Complete response rate leading to over 4 years overall survival

Quantity:

Add To Cart